임선민
#폐암#두경부암#기타원발미상암#항암약물치료#신약치료
|
학력
ㆍ 연세대학교 의과대학 의학과 학사 (2008)
ㆍ 연세대학교 대학원 의학과 석박사 (2017)
ㆍ 연세대학교 대학원 의학과 석박사 (2017)
경력
ㆍ 2008-2009 세브란스병원 인턴
ㆍ 2009-2013 세브란스병원 전공의
ㆍ 2013-2015 연세의대 내과학교실 종양내과 강사
ㆍ 2015-2020 분당차병원 혈액종양내과 조교수
ㆍ 2020-현재 연세의대 내과학교실 종양내과 임상조교수
ㆍ 2009-2013 세브란스병원 전공의
ㆍ 2013-2015 연세의대 내과학교실 종양내과 강사
ㆍ 2015-2020 분당차병원 혈액종양내과 조교수
ㆍ 2020-현재 연세의대 내과학교실 종양내과 임상조교수
논문
Association between Blood Pressure and Carotid Intima-Media Thickness
Journal Of Pediatrics 154/5 :667-671,2009
Fever-Induced QTc Prolongation and Ventricular Fibrillation in a Healthy Young Man
YONSEI MEDICAL JOURNAL 52/6 :1025-1027,2011
Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 23/11 :1080-1081,2011
Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24/2 :215-216,2012
Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation
DIGESTIVE DISEASES AND SCIENCES 57/6 :1682-1691,2012
Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer
ONCOLOGY 83/5 :292-299,2012
Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
YONSEI MEDICAL JOURNAL 53/2 :352-357,2012
Quantitative Analysis of ERK Signaling Inhibition in Colon Cancer Cell Lines Using Phospho-Specific Flow Cytometry
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 34/ :309-316,2012
A Case of Synchronous Squamous Cell Carcinoma in the Esophagus and Stomach
GUT AND LIVER 6/ :118-121,2012
The Effect of the Menstrual Cycle on Inflammatory Bowel Disease: A Prospective Study
GUT AND LIVER 7/1 :51-57,2013
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer.
JOURNAL OF CLINICAL ONCOLOGY 31/6 :731-737,2013
Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
FUTURE ONCOLOGY 9/3 :377-386,2013
Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
GUT AND LIVER 7/3 :329-334,2013
Impact of cumulative time on the clinical outcomes of endoscopic submucosal dissection in gastric neoplasm
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 27/4 :1397-1403,2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
LUNG CANCER 80/3 :313-318,2013
Combination of CYP Inhibitor with MEK/ERK Inhibitor Enhances the Inhibitory Effect on ERK in BRAF Mutant Colon Cancer Cells
ANTICANCER RESEARCH 33/6 :2499-2508,2013
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/ :825-835,2013
Psychosocial Impact of Cancer Patients on Their Family Members
Cancer Research and Treatment 45/3 :226-233,2013
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
ANNALS OF ONCOLOGY 24/12 :3089-3094,2013
Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study
JOURNAL OF CLINICAL PATHOLOGY 67/1 :33-39,2014
Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome
WORLD JOURNAL OF GASTROENTEROLOGY 20/8 :2042-2050,2014
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
LUNG CANCER 83/3 :374-382,2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
LUNG CANCER 83/3 :389-395,2014
A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer
JOURNAL OF MOLECULAR DIAGNOSTICS 16/2 :229-243,2014
Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements
PLOS ONE 9/Issue 7 :e103333-,2014
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
CANCER RESEARCH AND TREATMENT 47/1 :9-17,2015
Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study
PLOS ONE 10/5 :e0125238-,2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer
EUROPEAN JOURNAL OF CANCER 51/12 :1588-1595,2015
Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme
PLOS ONE 10/9 :e0137678-,2015
Clinical Implications from a Single-Center Study of Colorectal Adenocarcinoma in Transplant Recipients
ONCOLOGY 88/4 :195-200,2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
MOLECULAR CANCER THERAPEUTICS 14/10 :2238-2248,2015
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
PHARMACOGENETICS AND GENOMICS 26/3 :116-125,2016
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
LUNG CANCER 93/0 :1-8,2016
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients
BMC CANCER 16/1 :385-,2016
Targeted sequencing identifies genetic alterations that confer Primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
ONCOTARGET 7/24 :36,311-36,320,2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
LUNG CANCER 95/ :57-64,2016
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
ONCOTARGET 7/17 :24,172-24,178,2016
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 77/3 :539-548,2016
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
ONCOTARGET 7/9 :10,547-10,556,2016
EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
MOLECULAR CANCER THERAPEUTICS 15/7 :1,627-1,636,2016
Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma.
CANCER RESEARCH AND TREATMENT 49/01 :185-192,2017
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non?Small Cell Lung Cancer
JOURNAL OF THORACIC ONCOLOGY 12/3 :491-500,2017
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
JOURNAL OF CLINICAL ONCOLOGY 35/23 :2,613-2,618,2017
Journal Of Pediatrics 154/5 :667-671,2009
Fever-Induced QTc Prolongation and Ventricular Fibrillation in a Healthy Young Man
YONSEI MEDICAL JOURNAL 52/6 :1025-1027,2011
Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 23/11 :1080-1081,2011
Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24/2 :215-216,2012
Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation
DIGESTIVE DISEASES AND SCIENCES 57/6 :1682-1691,2012
Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer
ONCOLOGY 83/5 :292-299,2012
Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
YONSEI MEDICAL JOURNAL 53/2 :352-357,2012
Quantitative Analysis of ERK Signaling Inhibition in Colon Cancer Cell Lines Using Phospho-Specific Flow Cytometry
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 34/ :309-316,2012
A Case of Synchronous Squamous Cell Carcinoma in the Esophagus and Stomach
GUT AND LIVER 6/ :118-121,2012
The Effect of the Menstrual Cycle on Inflammatory Bowel Disease: A Prospective Study
GUT AND LIVER 7/1 :51-57,2013
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer.
JOURNAL OF CLINICAL ONCOLOGY 31/6 :731-737,2013
Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
FUTURE ONCOLOGY 9/3 :377-386,2013
Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
GUT AND LIVER 7/3 :329-334,2013
Impact of cumulative time on the clinical outcomes of endoscopic submucosal dissection in gastric neoplasm
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 27/4 :1397-1403,2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
LUNG CANCER 80/3 :313-318,2013
Combination of CYP Inhibitor with MEK/ERK Inhibitor Enhances the Inhibitory Effect on ERK in BRAF Mutant Colon Cancer Cells
ANTICANCER RESEARCH 33/6 :2499-2508,2013
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/ :825-835,2013
Psychosocial Impact of Cancer Patients on Their Family Members
Cancer Research and Treatment 45/3 :226-233,2013
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
ANNALS OF ONCOLOGY 24/12 :3089-3094,2013
Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study
JOURNAL OF CLINICAL PATHOLOGY 67/1 :33-39,2014
Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome
WORLD JOURNAL OF GASTROENTEROLOGY 20/8 :2042-2050,2014
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
LUNG CANCER 83/3 :374-382,2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
LUNG CANCER 83/3 :389-395,2014
A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer
JOURNAL OF MOLECULAR DIAGNOSTICS 16/2 :229-243,2014
Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements
PLOS ONE 9/Issue 7 :e103333-,2014
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
CANCER RESEARCH AND TREATMENT 47/1 :9-17,2015
Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study
PLOS ONE 10/5 :e0125238-,2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer
EUROPEAN JOURNAL OF CANCER 51/12 :1588-1595,2015
Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme
PLOS ONE 10/9 :e0137678-,2015
Clinical Implications from a Single-Center Study of Colorectal Adenocarcinoma in Transplant Recipients
ONCOLOGY 88/4 :195-200,2015
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
MOLECULAR CANCER THERAPEUTICS 14/10 :2238-2248,2015
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
PHARMACOGENETICS AND GENOMICS 26/3 :116-125,2016
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
LUNG CANCER 93/0 :1-8,2016
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients
BMC CANCER 16/1 :385-,2016
Targeted sequencing identifies genetic alterations that confer Primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
ONCOTARGET 7/24 :36,311-36,320,2016
ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
LUNG CANCER 95/ :57-64,2016
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
ONCOTARGET 7/17 :24,172-24,178,2016
A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 77/3 :539-548,2016
Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
ONCOTARGET 7/9 :10,547-10,556,2016
EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
MOLECULAR CANCER THERAPEUTICS 15/7 :1,627-1,636,2016
Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma.
CANCER RESEARCH AND TREATMENT 49/01 :185-192,2017
Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non?Small Cell Lung Cancer
JOURNAL OF THORACIC ONCOLOGY 12/3 :491-500,2017
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
JOURNAL OF CLINICAL ONCOLOGY 35/23 :2,613-2,618,2017
저서
저서 내용이 없습니다.
보도자료
확장병기 소세포폐암에서 '키트루다+화학요법' 치료 효과 확인
http://v.media.daum.net/v/20200619180617388?f=o
[병원소식] 노원을지대학교병원 병리과 김주영 교수 SCI 논문 게재
http://v.media.daum.net/v/20200619091021383?f=o
소세포폐암환자 생존연장에 면역항암제+화학요법 효과확인
https://cp.news.search.daum.net/p/94251615
http://v.media.daum.net/v/20200619180617388?f=o
[병원소식] 노원을지대학교병원 병리과 김주영 교수 SCI 논문 게재
http://v.media.daum.net/v/20200619091021383?f=o
소세포폐암환자 생존연장에 면역항암제+화학요법 효과확인
https://cp.news.search.daum.net/p/94251615
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.